Factors Associated with Severe Human Rift Valley Fever in Sangailu, Garissa County, Kenya-Reference-Cited by-同舟云学术

Factors Associated with Severe Human Rift Valley Fever in Sangailu, Garissa County, Kenya

Published:2015-03-12 Issue:3 Volume:9 Page:e0003548
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

LaBeaud A. Desirée,Pfeil Sarah,Muiruri Samuel,Dahir Saidi,Sutherland Laura J.,Traylor Zachary,Gildengorin Ginny,Muchiri Eric M.,Morrill John,Peters C. J.,Hise Amy G.,Kazura James W,King Charles H.

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference23 articles.

1. Risk factors for severe Rift Valley fever infection in Kenya, 2007;AS Anyangu;Am J Trop Med Hyg,2010

2. An outbreak of Rift Valley fever in Northeastern Kenya, 1997–98;CW Woods;Emerg Infect Dis,2002

3. Rift Valley Fever: scientific pathways toward public health prevention and response;RF Breiman;Am J Trop Med Hyg,2010

4. CDC (2007) Rift Valley Fever. Viral Hemorrhagic Fevers: Fact Sheets. pp.1–3.

5. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya;AD LaBeaud;Emerg Infect Dis,2008

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The socioeconomic impacts of Rift Valley fever: A rapid review;PLOS Neglected Tropical Diseases;2024-08-29

2. The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation;PLOS Neglected Tropical Diseases;2024-08-19

3. Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis;Pathogens;2024-07-13

4. The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation;2024-02-22

5. Bunyavirales;Molecular Medical Microbiology;2024